Birth outcomes in primiparous women diagnosed with fetal macrosomia and managed with active surveillance and watch-and-wait approach


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim: To compare specific features of delivery in primiparous women diagnosed with fetal macrosomia and managed with the watch-and-wait approach. Materials and methods: The study included 328 primiparous women, who had no carbohydrate metabolism disorders in pregnancy and delivered infants with birth weight 4000-4999 g at 390- 416 weeks of gestation: the active surveillance (pre-induction of labor) was applied to 38 patients at 390-6 weeks of pregnancy; and the watch-and-wait approach (spontaneous delivery and medical indications for induced labor)was applied to 290 patients at 400-6 and 410-6 weeks of pregnancy. Results: The rate of cesarean section was significantly high, when active surveillance was used at 390-6 weeks of pregnancy versus the watch-and-wait approach at 400-6 weeks of pregnancy (55.3% versus 26.8%, p=0.001). Moreover, in the group of women with pre-induction of labor at 390-6 weeks of pregnancy, premature rupture of membranes and low amniotic fluid for a long time (for more than 12 hours) increased the risk of infectious complications, andprophilactic antimicrobial therapy was used to prevent them (p<0,05). The watch-and-wait approach after 41 weeks of pregnancy contributed to increased incidence of chronic fetal hypoxia (p<0.05). Conclusion: The watch-and wait approach used in primiparous women, who had no carbohydrate metabolism disorders and diagnosed with fetal macrosomia before 400-6 weeks of pregnancy allows to decrease the rate of cesarean section and does not increase the incidence of adverse maternal outcomes (perineal trauma, hypotonic bleeding, endometritis) and perinatal outcomes (clavicle fracture, cephalohematoma, neonatal jaundice).

Full Text

Restricted Access

About the authors

Victoria A. Odinokova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology Ministry of Health of Russia

Email: v_odinokova@oparina4.ru
postgraduate student 117997, Russian Federation, Moscow, Oparin str., 4

Roman G. Shmakov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology Ministry of Health of Russia

Email: r_shmakov@oparina4.ru
Dr. Med. Sci., Professor of the RAS 117997, Russian Federation, Moscow, Oparin str., 4

References

  1. Macrosomia: ACOG Practice Bulletin, Number 216. Obstet. Gynecol. 2020; 135(1): e18-e35. https://dx.doi.org/10.1097/AOG.0000000000003606.
  2. Ye J., Torloni M.R., Ota E., Jayaratne K., Pileggi-Castro C., Ortiz-Panozo E. et al. Searching for the definition of macrosomia through an outcome-based approach in low- and middle-income countries: a secondary analysis of the WHO Global Survey in Africa, Asia and Latin America. BMC Pregnancy Childbirth. 2015; 15: 324. https://dx.doi.org/10.1186/s12884-015-0765-z.
  3. Черепнина А.Л., Панина О.Б., Олешкевич Л.Н. Ведение беременности и родов при крупном плоде. Вопросы гинекологии, акушерства и перинатологии. 2005; 1: 15-9.
  4. Luhete P.K., Mukuku O., Kiopin P.M., Tambwe A.M., Kayamba P.K. Fetal macrosomia in Lubumbashi: risk factors and maternal and perinatal prognosis. Pan. Afr. Med. J. 2016; 23: 166. https://dx.doi.org/10.11604/pamj.2016.23.166.7362.
  5. Garca-De la Torre J.I., Rodriguez-Valdez A., Delgado-Rosas A. Risk factors for fetal macrosomia in patients without gestational diabetes mellitus. Ginecol. Obstet. Mex. 2016; 84(3): 164-71.
  6. Wassimi S., Wilkins R., Mchugh N.G., Xiao L., Simonet F., Luo Z.C. Association of macrosomia with perinatal and postneonatal mortality among First Nations people in Quebec. CMAJ. 2011; 183(3): 322-6. https://dx.doi.org/10.1503/cmaj.100837.
  7. Sokol R.J., Blackwell S.C.; American College of Obstetricians and Gynecologists.Committee on Practice Bulletins-Gynecology. ACOG practice bulletin: Shoulder dystocia. Number 40, November 2002. (Replaces practice pattern number, October 1997).Int. J. Gynaecol. Obstet. 2003; 80(1): 87-92. https://dx.doi.org/10.1016/s0020-7292(02)90001-9.
  8. Cheng Y.W., Sparks T.N., Laros R.K. Jr, Nicholson J.M., Caughey A.B. Impending macrosomia: will induction of labour modify the risk of caesarean delivery? BJOG. 2012(4); 119: 402-9. https://dx.doi.org/10.1111/j.1471-0528.2011.03248.x.
  9. Sanchez-Ramos L., Bernstein S., Kaunitz A.M. Expectant management versus labor induction for suspected fetal macrosomia: a systematic review. Obstet. Gynecol. 2002; 100(5, Pt. 1): 997-1002.
  10. Combs C.A., Singh N.B., Khoury J.C. Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia. Obstet. Gynecol. 1993; 81(4): 492-6.
  11. Friesen C.D., Miller A.M., Rayburn W.F. Influence of spontaneous or induced labor on delivering the macrosomic fetus. Am. J. Perinatol. 1995; 12(1): 63-6. https://dx.doi.org/10.1055/s-2007-994404.
  12. Leaphart W.L., Meyer M.C., Capeless E.L. Labor induction with a prenatal diagnosis of fetal macrosomia. J. Matern. Fetal. Med. 1997; 6(2): 99-102. https://dx.doi.org/10.1002/(SICI)1520-6661(199703/04)6:2<99:: AID-MFM7>3.0.CO;2-K.
  13. Vendittelli F., Riviere O., Neveu B., Lemery D.; Audipog Sentinel Network. Does induction of labor for constitutionally large-for-gestational-age fetuses identified in utero reduce maternal morbidity? BMC Pregnancy Childbirth. 2014; 14: 156. https://dx.doi.org/10.1186/1471-2393-14-156.
  14. Boulvain M., Marcoux S., Bureau M., Fortier M., Fraser W. Risks of induction of labour in uncomplicated term pregnancies. Paediatr. Perinat. Epidemiol. 2001; 15(2): 131-8. https://dx.doi.org/10.1046/j.1365-3016.2001.00337.x.
  15. Caughey A.B. Should pregnancies be induced for impending macrosomia? Lancet. 2015; 385(9987): 2557-9. https://dx.doi.org/10.1016/S0140-6736(14)62302-3.
  16. Royal College of Obstetricians and Gynaecologists (RCOG). Shoulder Dystocia. Green-top Guideline No. 42. London: RCOG; 2005 (update 2017).
  17. National Institute for Health and Care Excellence. NICE Guidence: induction of labour. Evidence Update July 2013. Evidence. 2013; 44: 1-124.
  18. Clinical Practice Obstetrics Committee, Society of Obsetricians and Gynaecologists of Canada. Induction of labour. SOGC Clinical Practice Guideline No. 296, September 2013.
  19. WHO recommendations: induction of labour at or beyond term. Geneva: World Health Organization; 2018.
  20. Wormer K.C., Bauer A., Williford A.E. Bishop Score. In: StatPearls. Treasure Island, FL: StatPearls Publishing. 2021.
  21. Gonen O., Rosen D.J., Dolfin Z., Tepper R., Markov S., Fejgin M.D. Induction of labor versus expectant management in macrosomia: a randomized study. Obstet. Gynecol. 1997;89(6):913-7.https://dx.doi.org/10.1016/s0029-7844(97)00149-x.
  22. Magro-Malosso E.R., Saccone G., Chen M., Navathe R., Di Tommaso M., Berghella V. Induction of labour for suspected macrosomia at term in non-diabetic women: a systematic review and metaanalysis of randomized controlled trials. BJOG. 2017; 124(3): 414-21. https://dx.doi.org/10.1111/1471-0528.14435.
  23. Tey A., Eriksen N.L., Blanco J.D. A prospective randomized trial of induction versus expectant management in nondiabetec pregnancies with fetal macrosomia. Am. J. Obstet. Gynecol. 1995; 172(1): 203. https://dx.doi.org/10.1016/0002-9378(95)90803-x.
  24. Vitner D., Bleicher I., Kadour-Peero E., Borenstein-Levin L., Kugelman A., Sagi S., Gonen R. Induction of labor versus expectant management among women with macrosomic neonates. A retrospective study. J. Matern. Fetal Neonatal Med. 2020; 33(11): 1831-9. https://dx.doi.org/10.1080/14767058.2018.1531121.
  25. Boulet S. L., Alexander G. R., Sali hu H.M., Pass M. Macrosomic births in the United States: Determinants, outcomes and prposed grades of risk. Am. J. Obstet. Gynecol. 2003; 188(5): 1372-8. https://dx.doi.org/10.1067/mob.2003.302.
  26. Boulvain M., Senat M. V., Perrotin F., Winer N., Beucher G., Subtil D. et al. Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. Lancet. 2015; 385(9987): 2600-5. https://dx.doi.org/10.1016/S0140-6736(14)61904-8.
  27. Sinclair B.A., Rowan J.A., Hainsworth O.T. Macrosomic infants are not all equal. Aust. N.Z.J. Obstet. Gynaecol. 2007; 47(2): 101-5. https://dx.doi.org/10.1111/j.1479-828X.2007.00694.x.
  28. Баева И.Ю., Константинова О.Д. Крупный плод: тактика ведения родов. Российский вестник акушера-гинеколога. 2015; 15(3): 44-7. https://dx.doi.org/10.17116/rosakush201515344-47.
  29. Тысячный О.В., Баев О.Р., Кречетова Л.В. Течение и исходы родов в зависимости от тактики ведения при пролонгированной беременности. Акушерство и гинекология. 2016; 7: 28-33. https://dx.doi.org/10.18565/aig.2016.7.28-33.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies